DAVID POPLACK to Burkitt Lymphoma
This is a "connection" page, showing publications DAVID POPLACK has written about Burkitt Lymphoma.
Connection Strength
0.116
-
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6.
Score: 0.034
-
Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia. 1994 Jun; 8(6):963-7.
Score: 0.025
-
Lactate dehydrogenase isoenzymes in normal and malignant human lymphoid cells. Blood. 1982 Aug; 60(2):491-4.
Score: 0.011
-
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr; 68(4):486-91.
Score: 0.009
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.008
-
The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer. 1978 Jun; 41(6):2431-7.
Score: 0.008
-
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63.
Score: 0.008
-
A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Res. 1975 Dec; 35(12):3715-20.
Score: 0.007
-
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb; 89(2):640-7.
Score: 0.005